New study tracks RSV vaccine safety in 3,000 korean kids
NCT ID NCT07200206
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 31 times
Summary
This study is checking the safety of Beyfortus, a medicine to prevent RSV, in Korean children up to 2 years old. About 3,000 kids will be watched for 6 months after getting the shot. The goal is to see if any side effects happen in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nam Seung Woo Pediatric: 4100007
RECRUITINGHwaseong-si, Gyeonggi-do, 18478, South Korea
Conditions
Explore the condition pages connected to this study.